Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | Get druggable targets OG5_139225 | All targets in OG5_139225 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0578 | 0.3391 | 0.3431 | |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0497 | 0.2796 | 1 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0497 | 0.2796 | 0.5 |
Brugia malayi | Hemopexin family protein | 0.0578 | 0.3391 | 0.2947 |
Loa Loa (eye worm) | hypothetical protein | 0.0408 | 0.2146 | 0.0428 |
Loa Loa (eye worm) | hypothetical protein | 0.0408 | 0.2146 | 0.0428 |
Onchocerca volvulus | Matrilysin homolog | 0.0904 | 0.5775 | 1 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0979 | 0.6322 | 0.6322 |
Schistosoma mansoni | hypothetical protein | 0.0578 | 0.3391 | 1 |
Brugia malayi | Matrixin family protein | 0.0986 | 0.6371 | 1 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0408 | 0.2146 | 0.5701 |
Loa Loa (eye worm) | hypothetical protein | 0.0497 | 0.2796 | 0.1899 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.1483 | 1 | 1 |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.0408 | 0.2146 | 0.5701 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0662 | 0.0577 |
Echinococcus multilocularis | adam 17 protease | 0.0182 | 0.0495 | 0.0495 |
Loa Loa (eye worm) | matrixin family protein | 0.0986 | 0.6371 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0662 | 0.0577 |
Echinococcus granulosus | geminin | 0.0205 | 0.0662 | 0.0662 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0904 | 0.5775 | 1 |
Loa Loa (eye worm) | matrix metalloproteinase | 0.0408 | 0.2146 | 0.0428 |
Loa Loa (eye worm) | matrixin family protein | 0.0904 | 0.5775 | 0.865 |
Loa Loa (eye worm) | hypothetical protein | 0.0408 | 0.2146 | 0.0428 |
Echinococcus multilocularis | geminin | 0.0205 | 0.0662 | 0.0662 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0497 | 0.2796 | 0.1537 |
Mycobacterium ulcerans | hydrolase | 0.0497 | 0.2796 | 0.5 |
Echinococcus granulosus | adam 17 protease | 0.02 | 0.0627 | 0.0627 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.058 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 0.4467 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 0.631 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 2.3109 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 2.6169 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 5.6234 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.5131 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 63.0957 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.